US Patent 9486429 Therapeutic methods employing nitric oxide precursors
Patent 9486429 was granted and assigned to Vanderbilt University on November, 2016 by the United States Patent and Trademark Office.
All edits
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
US Patent 09486429 Therapeutic methods employing nitric oxide precursors US Patent 9486429 Therapeutic methods employing nitric oxide precursors
US Patent 09486429 Therapeutic methods employing nitric oxide precursors
Find more entities like US Patent 9486429 Therapeutic methods employing nitric oxide precursors
